v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

ASSESSMENT OF ATTAINMENT OF CARDIOVASCULAR TARGETS IN DIABETIC PATIENTS AND FACTORS FORECASTING GOAL ACCOMPLISHMENT

AUTHORS:

Dr. Iqra Razzaq, Dr. Ayesha Hashmi, Dr. Afsah Farooq

ABSTRACT:

Treatment of type 2 diabetes requires control of hyperglycemia, hyperlipidemia, and close monitoring of hypertension. Measuring exposure to these factors helps assess patients' risk for primary cardiovascular prophylaxis, and achieving goals helps control the cardiovascular system. Place and Duration: In the Medicine Units of Jinnah Hospital Lahore for one year duration from February 2019 to February 2020. Patients and methods: A cross-sectional study was performed on three hundred patients who referred to hospitals and outpatient clinics. Three basic parameters of HbA1c, systolic blood pressure and LDL-C have been registered. Patients were divided into two groups as HbA1c 7 7%, systolic blood pressure ≤140 mmHg and LDL-C ≤ 100 mg / dl in accordance with the above-mentioned objectives. Patients who achieved all three goals were compared with those who did not achieve diabetes, body mass index, and glucose lowering therapy, cardiovascular therapy, and micro- and macro vascular complications. Results: Out of 300 patients, only 14 patients achieved all three goals and 102 patients did not achieve any of these goals (p = 0.021). There was no significant difference between the two groups of patients in terms of micro- and macro-vascular complications (p = 0.48). There was no significant difference in cardiovascular treatment between the two groups (p = 0.52). There was no significant difference between diabetes (p = 0.41), gender (p = 0.38), body mass index (p = 0.64) and duration of diabetes (diabetes (p = 0.56)). However, the study population has a high incidence of obesity. Conclusion: A low percentage of diabetic patients meets all recommended goals. Good blood pressure, blood sugar and hyperlipidemia are recommended to prevent complications in diabetic patients.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.